Condition

Interstitial Lung Diseases clinical trials and research

• 10Clinical trials
• 10NIH research projects
• 22Countries

Newest Interstitial Lung Diseases clinical trials

All recruiting trials (10)

• Home-based pulmonary rehabilitation for interstitial lung disease

  This study tests a 6-week home-based pulmonary rehabilitation program to see if it improves breathing, exercise ability, and quality of life for people with fibrotic interstitial lung disease in India.

  Recruiting Post Graduate Institute of Medical Education and Research, Chandigarh · Chandigarh, Chandigarh · NCT07830602

• Photon-counting CT vs standard HRCT to help diagnose IPF and other ILDs

  This study tests whether photon-counting CT can improve identifying IPF and other ILDs compared with standard HRCT for patients discussed in multidisciplinary teams.

  Recruiting Istituto Clinico Humanitas · Rozzano, Italy · NCT07790614

• Nerandomilast for fibrosing interstitial lung disease at risk of progression

  This trial tests whether nerandomilast can help adults with fibrosing interstitial lung disease who are at risk of their disease getting worse.

  Recruiting at 7 sites Phase 3 Boehringer Ingelheim · Birmingham, Alabama and 161 other locations · NCT07540988

• Nerandomilast to slow lung changes in people with a family history of pulmonary fibrosis

  This trial tests whether taking nerandomilast can slow early lung scarring in people aged 40 and older who have a first-degree relative with pulmonary fibrosis and CT evidence of interstitial lung abnormalities.

  Recruiting at 52 sites Phase 3 Boehringer Ingelheim · Los Angeles, California and 54 other locations · NCT07201922

• Ultra‑high‑resolution CT to look for lung and heart damage in progressive interstitial lung disease

  This project will use advanced multidimensional CT scans to see if one noninvasive test can measure both lung fibrosis and early heart involvement in adults with progressive or long‑standing interstitial lung disease.

  Recruiting IRCCS San Raffaele · Milan · NCT06537934

• Evaluating a new CAR T cell therapy for systemic sclerosis

  This study is testing a new CAR T cell therapy to see if it can help people with systemic sclerosis feel better and manage their symptoms.

  Recruiting at 10 sites Phase 2/3 Cabaletta Bio · New Haven, Connecticut and 9 other locations · NCT06328777

• Understanding functional status in people with interstitial lung disease

  This study is trying to understand how interstitial lung disease affects people's daily activities and overall health, while also looking at what factors might make it worse.

  Recruiting Aveiro University · Aveiro · NCT06317831

• Using ultrasound to evaluate lung diseases

  This study is testing whether lung ultrasound can help doctors better understand and monitor lung diseases like interstitial lung disease and COPD in both hospital patients and those visiting outpatient clinics.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT06068647

• Observational study on interstitial lung diseases from infancy to elderly

  This study is collecting health information from people of all ages with interstitial lung diseases to see how these conditions affect them over time.

  Recruiting Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT06036719

• Observing the natural progression of interstitial lung disease

  This study is collecting data and blood samples from people with interstitial lung disease to see how the condition progresses over time and to better understand its effects.

  Recruiting University of Chicago · Chicago, Illinois · NCT00470327

NIH-funded research (10)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• How lung cells and their surroundings drive fibrosis in interstitial lung diseases

  A study to understand how airway cells, surrounding tissue, and their environment contribute to progressive scarring in interstitial lung diseases.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-11412613

• Quantitative Ultrasound for Lung Diseases in People

  A new ultrasound approach to measure how bad heart- or fibrosis-related lung problems are, using real-time, noninvasive imaging in people.

  NIH research North Carolina State University Raleigh · Raleigh, United States · NIH-11367435

• Better Lung Imaging for Conditions like Pulmonary Fibrosis

  This work explores a new ultrasound method to better track lung conditions like heart failure-related fluid buildup and idiopathic pulmonary fibrosis in people.

  NIH research North Carolina State University Raleigh · Raleigh, United States · NIH-11193973

• How lung cell and tissue interactions cause scarring in interstitial lung disease

  This project looks at how injured lung lining cells talk with nearby cells and the surrounding tissue to cause scarring in people with interstitial lung disease.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-11178483

• Investigating personalized treatment options for Idiopathic Pulmonary Fibrosis using genetic information.

  This study is looking to help people with Idiopathic Pulmonary Fibrosis (IPF) by using their genetic information to find the best treatments for them, so they can get care that’s more personalized and effective.

  NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11075126

• Investigating personalized treatment options for Idiopathic Pulmonary Fibrosis using genetic information

  This study is looking to make treatments for Idiopathic Pulmonary Fibrosis (IPF) better by using genetic information to find out how different people respond to medications like N-Acetylcysteine, so that doctors can provide more personalized care for patients with lung diseases.

  NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11071971

• Identifying immune cell changes in chronic lung diseases using advanced sequencing techniques.

  This study is looking at how immune cells change in people with chronic lung diseases to find new ways to diagnose and treat conditions like idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis, using a simple blood test.

  NIH research Yale University · New Haven, United States · NIH-11017010

• Investigating the role of the complement pathway in lung diseases

  This study is looking at how certain proteins in your body might help us understand the progression of idiopathic pulmonary fibrosis and similar lung diseases, so we can find better treatments tailored just for you.

  NIH research Duke University · Durham, United States · NIH-11011341

• Understanding how cell interactions contribute to lung disease fibrosis

  This study is looking at how different cells in the lungs work together to cause scarring in interstitial lung diseases, especially in the early stages, to help find new ways to treat the condition.

  NIH research University of California Los Angeles · Los Angeles, United States · NIH-10975694

• Using ultrasound to assess lung diseases like pulmonary edema and fibrosis

  This study is looking at how low-quality ultrasound can help check the severity of lung problems like fluid buildup from heart failure and lung scarring, aiming to offer a safer and cheaper way to monitor these conditions without the radiation from X-rays or CT scans.

  NIH research North Carolina State University Raleigh · Raleigh, United States · NIH-10945844

Related topics

Quick answers

How many Interstitial Lung Diseases clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in Italy (5 trials), United States (4 trials), France (3 trials), Argentina (2 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →